AN2 Therapeutics (ANTX) Assets (2021 - 2026)
AN2 Therapeutics (ANTX) recorded Assets of $81.68 million in Q2 2026, up 7.7% from $75.83 million a year earlier but down 6.6% from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, AN2 Therapeutics reported Assets of $61.95 million, down 32.7% from FY2024.
- Annual Assets has a four-year compound annual growth rate of -1.3% (FY2021 to FY2025).
- Across earlier years, Assets came in at $92.09 million in FY2024 (-33.6%), $138.74 million in FY2023 (+35.3%), $102.56 million in FY2022 (+57.0%) and $65.32 million in FY2021.
- Quarterly Assets has ranged from $61.95 million in Q4 2025 to $153.81 million in Q3 2023 over the past five years.
- On a year-over-year basis, Assets rose in two of the last eight quarters, with an average decline of 22.7%.
- Peak year-over-year performance for Assets in the last five years was growth of 57.0% in Q4 2022, against a decline of 36.5% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $87.49 million (Q1 2026), $61.95 million (Q4 2025) and $67.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | AN2 Therapeutics | 181.91 Mn | 181.91 Mn | - | 81.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.68 Mn |
| Mar 31, 2026 | 87.49 Mn |
| Dec 31, 2025 | 61.95 Mn |
| Sep 30, 2025 | 67.24 Mn |
| Jun 30, 2025 | 75.83 Mn |
| Mar 31, 2025 | 81.34 Mn |
| Dec 31, 2024 | 92.09 Mn |
| Sep 30, 2024 | 97.69 Mn |
| Jun 30, 2024 | 108.48 Mn |
| Mar 31, 2024 | 121.26 Mn |
| Dec 31, 2023 | 138.74 Mn |
| Sep 30, 2023 | 153.81 Mn |
| Jun 30, 2023 | 98.93 Mn |
| Mar 31, 2023 | 91.08 Mn |
| Dec 31, 2022 | 102.56 Mn |
| Sep 30, 2022 | 110.01 Mn |
| Jun 30, 2022 | 120.02 Mn |
| Mar 31, 2022 | 120.50 Mn |
| Dec 31, 2021 | 65.32 Mn |
API Access
AN2 Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();